TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31226679

Group type: EXPERIMENTAL
Intervention: Measurement of occipital condyle‐C1 interval (CCI)
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of atlantodental interval (ADI)
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of basion‐dens interval (BDI)
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of pB‐C2
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of PADI
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of basion‐axial interval (BAI)
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of basion‐opisthion diameter (BOD)
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of dens angulation
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Measurement of canal diameter at C1
Number of subjects: 1458
Study: 27237928

Group type: EXPERIMENTAL
Intervention: CFT + TAU
Number of subjects: 22

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 22
Study: 28700832

Group type: EXPERIMENTAL
Intervention: 12-week low-carbohydrate, high-fat diet
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional high-carbohydrate, low-fat diet
Number of subjects: 41
Study: 24227721

Group type: EXPERIMENTAL
Intervention: Activation in motor response control regions
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Activation in executive control regions
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Error-processing activation in the dorsal anterior cingulate cortex
Number of subjects: 123
Study: 21343330

Group type: EXPERIMENTAL
Intervention: Family psychoeducation (4 sessions of didactic lectures and group problem-solving)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Treatment as usual (Control group)
Number of subjects: 57
Study: 19574662

Group type: EXPERIMENTAL
Intervention: Kinesio Taping applied with tension
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham Kinesio Taping applied without tension
Number of subjects: 41
Study: 18264542

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair
Number of subjects: 359
Study: 15519187

Group type: EXPERIMENTAL
Intervention: Heparin dosage of 100 iu/kg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Heparin dosage of 200 iu/kg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Heparin dosage of 250 iu/kg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Heparin dosage of 300 iu/kg
Number of subjects: 195
Study: 11212998

Group type: EXPERIMENTAL
Intervention: Community-based model of continuity of care (n = 550)
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Standard hospital-based care (n = 539)
Number of subjects: 1089
Study: 8616834

Group type: EXPERIMENTAL
Intervention: GSTM3 AA genotype
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: GSTM3 AA in combination with skin type 1, GSTM1 null, and CYP1A1 m1m1
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: GSTM3 BB genotype
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: GSTM1 A/B genotype
Number of subjects: 586
Study: 1611985

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam, 1.5 mg/kg tramadol, 50 mg alizaprid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam, 0.2 mg/kg nalbuphine, 50 mg alizaprid
Number of subjects: 150
Study: 4030188

Group type: EXPERIMENTAL
Intervention: Testosterone and anabolic steroids (average 57 +/- 24.9 mg/day for 6 months)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Testosterone and anabolic steroids
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study: 31664592

Group type: EXPERIMENTAL
Intervention: Crossover design with interleaving cohorts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parallel group design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crossover designs
Number of subjects: 0

Group type: COMPARATOR
Intervention: All evaluated designs
Number of subjects: 0
Study: 30586364

Group type: EXPERIMENTAL
Intervention: Maraviroc alone or together with TDF or FTC
Number of subjects: 591

Group type: COMPARATOR
Intervention: TDF + FTC (control)
Number of subjects: 591
Study: 27993145

Group type: EXPERIMENTAL
Intervention: High-specification foam mattress
Number of subjects: 2954

Group type: COMPARATOR
Intervention: Alternating-pressure mattress
Number of subjects: 2954
Study: 24337350

Group type: EXPERIMENTAL
Intervention: LED therapy (λ of 640 ± 20 nm and spatial average energy fluency of 1.2 J/cm(2) during hospitalization)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: LED therapy (640 nm)
Number of subjects: 90
Study: 22371093

Group type: EXPERIMENTAL
Intervention: Bone-conducted music using the SwiMP3 device
Number of subjects: 24
Study: 19590469

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation course (MMC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Leadership course (control)
Number of subjects: 33
Study: 17878877

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation for HCC contacting large vessels (Group A)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Radiofrequency ablation for HCC away from large vessels (Group B)
Number of subjects: 26
Study: 15223187

Group type: EXPERIMENTAL
Intervention: Patients with frontotemporal dementia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study: 11245839

Group type: EXPERIMENTAL
Intervention: Attention-based visual routines involving dynamic patterns (e.g., pairs of points in orbiting motion, 11 points in biological motion)
Number of subjects: 0
Study: 9675625

Group type: EXPERIMENTAL
Intervention: Low doses of morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 0
Study: 10381659

Group type: EXPERIMENTAL
Intervention: Calcium ointment (10% w/w calcium carbonate) applied to lower lid skin twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Petrolatum without calcium carbonate (control)
Number of subjects: 0
Study: 2240692

Group type: EXPERIMENTAL
Intervention: Polyethylene Leader‐Cath 115‐09 catheter (group A)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Teflon Viggo Floswitch 4441 catheter (group B)
Number of subjects: 48
Study: 720774

Group type: EXPERIMENTAL
Intervention: Aspirin (10 gm over four days)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2

Group type: COMPARATOR
Intervention: Ibuprofen and ketoprofen
Number of subjects: 2
Study: 31121294

Group type: EXPERIMENTAL
Intervention: Cane group (using a cane whenever walking)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (not using any gait aid)
Number of subjects: 79
Study: 27334026

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Questionnaire assessing knowledge on FV intake guidelines
Number of subjects: 28
Study: 25677271

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Open colectomy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cholecystectomy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Colectomy patients developing POI
Number of subjects: 56
Study: 23314117

Group type: EXPERIMENTAL
Intervention: 20 min of video-based training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-ratings of performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-ratings of performance after training
Number of subjects: 0
Study: 21527597

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) plus 2 months of Tube Feeding (TF)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 103
Study: 19253241

Group type: EXPERIMENTAL
Intervention: Retrobulbar block (group R)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sub-Tenon block (group S)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (group T)
Number of subjects: 81
Study: 16952507

Group type: EXPERIMENTAL
Intervention: Sperm cryopreservation using a standard protocol with a test-yolk buffer, glycerol as the cryoprotectant
Number of subjects: 77
Study: 15041988

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plication of the endopelvic fascia
Number of subjects: 50
Study: 11747472

Group type: COMPARATOR
Intervention: Horse-chestnut seeds extract (HCSE) and compression therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Compression therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Horse-chestnut seeds extract (HCSE)
Number of subjects: 0
Study: 9230168

Group type: EXPERIMENTAL
Intervention: 4 hours of bed rest after coronary arteriography
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6 hours of bed rest after coronary arteriography
Number of subjects: 0
Study: 8232429

Group type: EXPERIMENTAL
Intervention: CHVP plus interferon alfa (5 million units three times weekly for 18 months)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: CHVP plus interferon alfa
Number of subjects: 242

Group type: COMPARATOR
Intervention: CHVP alone
Number of subjects: 242
Study: 3662273

Group type: EXPERIMENTAL
Intervention: Phenobarbital (FB)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Phenytoin (DPH)
Number of subjects: 17
Study: 31718842

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg monthly
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg pro re nata (PRN) after 3 loading doses
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Ranibizumab 2.0 mg monthly
Number of subjects: 1097

Group type: EXPERIMENTAL
Intervention: Ranibizumab 2.0 mg PRN
Number of subjects: 1097

Group type: COMPARATOR
Intervention: All ranibizumab doses
Number of subjects: 1097
Study: 29315411

Group type: EXPERIMENTAL
Intervention: CLOSE-guided PVI
Number of subjects: 50

Group type: COMPARATOR
Intervention: CONV-CF
Number of subjects: 50
Study: 29110687

Group type: COMPARATOR
Intervention: High-frequency rTMS (5 Hz) over the bilateral lower-limb motor area (Cz), 10 sessions.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham rTMS (control group).
Number of subjects: 20
Study: 26330595

Group type: EXPERIMENTAL
Intervention: Volar locking plate (n = 66)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Percutaneous fixation (n = 64)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Volar locking plate
Number of subjects: 130

Group type: COMPARATOR
Intervention: Volar locking plate relative to percutaneous fixation
Number of subjects: 130
Study: 22633653

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 346

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 346
Study: 20546157

Group type: EXPERIMENTAL
Intervention: Transseptal (TS) approach
Number of subjects: 22

Group type: COMPARATOR
Intervention: Transaortic (TA) approach
Number of subjects: 22
Study: 18502781

Group type: EXPERIMENTAL
Intervention: Nitroglycerine (IV 0.5 microg/kg/min for 20 min; n = 27)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 5)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nitroglycerine (IV 0.5 microg/kg/min for 20 min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15899749

Group type: EXPERIMENTAL
Intervention: Behavioral intervention for YPLH
Number of subjects: 0
Study: 12623815

Group type: EXPERIMENTAL
Intervention: PRK for myopia and astigmatism
Number of subjects: 19
Study: 10582840

Group type: EXPERIMENTAL
Intervention: ADHD combined type (DSM-IV)
Number of subjects: 0
Study: 8694682

Group type: EXPERIMENTAL
Intervention: Clomipramine for 9 months combined with 15 weekly sessions of brief dynamic psychotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clomipramine for 9 months
Number of subjects: 40
Study: 1931397

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) 0.05 mg kg‐1 or 0.1 mg kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 6285947

Group type: EXPERIMENTAL
Intervention: Large fractions of radiation with high-dose metronidazole
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Radiation as in Group 2 but with equitoxic doses of MISO
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional radiation alone
Number of subjects: 66
Study: 31687775

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation
Number of subjects: 3
Study: 28154331

Group type: EXPERIMENTAL
Intervention: Ephedra Herb extract (EFE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ephedra Herb
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EFE (different amounts)
Number of subjects: 12
Study: 26025218

Group type: EXPERIMENTAL
Intervention: Revascularization (percutaneous coronary intervention or coronary artery bypass graft) performed during index hospitalization in 8,586 patients (68.0%)
Number of subjects: 12635

Group type: COMPARATOR
Intervention: No revascularization
Number of subjects: 12635
Study: 25055754

Group type: EXPERIMENTAL
Intervention: Unipolar hemiarthroplasty
Number of subjects: 175

Group type: COMPARATOR
Intervention: Bipolar hemiarthroplasty
Number of subjects: 175
Study: 22249844

Group type: EXPERIMENTAL
Intervention: EDTA (24%)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PDGF (25 ng/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined application of EDTA and PDGF
Number of subjects: 40

Group type: COMPARATOR
Intervention: SRP (scaling root planing)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diseased (untreated)
Number of subjects: 40
Study: 20218746

Group type: EXPERIMENTAL
Intervention: Antiparasitic and anti-infective drugs
Number of subjects: 158
Study: 17548704

Group type: EXPERIMENTAL
Intervention: Total dietary iron intake
Number of subjects: 49654

Group type: EXPERIMENTAL
Intervention: Heme iron intake
Number of subjects: 49654

Group type: EXPERIMENTAL
Intervention: Iron intake in women consuming 30+ g of alcohol per day
Number of subjects: 49654

Group type: EXPERIMENTAL
Intervention: Iron intake in women who had ever used hormone replacement therapy
Number of subjects: 49654
Study: 15823510

Group type: EXPERIMENTAL
Intervention: Levetiracetam (1000-4000 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11953637

Group type: EXPERIMENTAL
Intervention: Intramedullary rod
Number of subjects: 18

Group type: COMPARATOR
Intervention: Two insertion techniques
Number of subjects: 18
Study: 9798656

Group type: EXPERIMENTAL
Intervention: Folate supplementation after one week of vitamins B6 and B12 supplementation.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Normal hemoglobin (HbAA) controls.
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vitamin B6 and B12 supplementation.
Number of subjects: 46
Study: 9638199

Group type: EXPERIMENTAL
Intervention: Transcutaneous oximetry measurements before and three weeks after surgery
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Transcutaneous oximetry measurements
Number of subjects: 172
Study: 2095023

Group type: COMPARATOR
Intervention: Mersilene interrupted sutures
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Single adjustable running Mersilene suture
Number of subjects: 68
Study: 705848

Group type: EXPERIMENTAL
Intervention: Single dose of 200 mg doxycycline
Number of subjects: 149

Group type: COMPARATOR
Intervention: Seven day course of tetracycline
Number of subjects: 149
Study: 31733275

Group type: EXPERIMENTAL
Intervention: Total serum PSA
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Free-PSA ratio
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: PSA density
Number of subjects: 603
Study: 30643398

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate inhalation solution (FFIS; 20 µg, n=541)
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Placebo (n=530)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Formoterol fumarate inhalation solution (FFIS)
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1071
Study: 25779636

Group type: EXPERIMENTAL
Intervention: Closed suction (CS) system
Number of subjects: 13

Group type: COMPARATOR
Intervention: Open suction (OS) system
Number of subjects: 13
Study: 26077038

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Albuterol
Number of subjects: 14
Study: 23442752

Group type: EXPERIMENTAL
Intervention: 20 ml mepivacaine 1%
Number of subjects: 10
Study: 21481449

Group type: EXPERIMENTAL
Intervention: Phentermine 7.5 mg plus topiramate 46.0 mg
Number of subjects: 2487

Group type: EXPERIMENTAL
Intervention: Phentermine 15.0 mg plus topiramate 92.0 mg
Number of subjects: 2487

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2487
Study: 19228842

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 4731
Study: 16374021

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 34

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 34
Study: 14652086

Group type: EXPERIMENTAL
Intervention: Caffeine+Nap (200 mg caffeine followed by a 20 min nap)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nap+Bright-light (2000 lx of bright light for 1 min after a 20 min nap)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nap+Face-washing (washing faces immediately after a 20 min nap)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nap only (20 min nap)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-Nap (rest without sleep)
Number of subjects: 10
Study: 11061612

Group type: EXPERIMENTAL
Intervention: Gemcitabine administered intravenously at 1250 mg/m2 over 30-60 minutes on days 1, 8, and 15 followed by 1 week of rest, maximum of six cycles
Number of subjects: 21
Study: 8550052

Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN-alpha) treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 35
Study: 1405579

Group type: EXPERIMENTAL
Intervention: Breakfast (B)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 35
Study: 2865188

Group type: EXPERIMENTAL
Intervention: SRM plus TTS‐TNG
Number of subjects: 10

Group type: COMPARATOR
Intervention: SRM alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29426869

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) - 2 placebo pills twice a day for 21 days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 74
Study: 27676665

Group type: EXPERIMENTAL
Intervention: Ketamine plus bupivacaine in Pecs block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine alone in Pecs block
Number of subjects: 60
Study: 24883390

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 23409612

Group type: EXPERIMENTAL
Intervention: Somatic acupuncture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ear acupuncture
Number of subjects: 35
Study: 19969355

Group type: EXPERIMENTAL
Intervention: Virtual Mentor program (digital video disc)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional teaching materials (control group)
Number of subjects: 68
Study: 18457463

Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 1042
Study: 15915022

Group type: EXPERIMENTAL
Intervention: 25 degrees head-up position
Number of subjects: 42

Group type: COMPARATOR
Intervention: supine position
Number of subjects: 42
Study: 15316804

Group type: EXPERIMENTAL
Intervention: Simulator based desensitisation exposure (Group S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Customised exercise regime (Group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Group C and Group S)
Number of subjects: 40
Study: 11556409

Group type: EXPERIMENTAL
Intervention: 75+HA conducted in the participant's home by a nurse
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 100
Study: 9431710

Group type: EXPERIMENTAL
Intervention: Cow udder ointment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Petrolatum (placebo)
Number of subjects: 30
Study: 8500321

Group type: EXPERIMENTAL
Intervention: Corneal arcus presence
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Old age and high LDL cholesterol concentration
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Ultrasonographically assessed atherosclerosis
Number of subjects: 447
Study: 3511410

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Pentazocin
Number of subjects: 42
Study: 29289490

Group type: EXPERIMENTAL
Intervention: PEEP-5 (5 cm H2O)
Number of subjects: 51

Group type: COMPARATOR
Intervention: PEEP-0 (no PEEP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both PEEP-0 and PEEP-5
Number of subjects: 51
Study: 27668723

Group type: EXPERIMENTAL
Intervention: Cognitive behavior psychophysiological therapy (CBPT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Music and relaxation therapy (MRT)
Number of subjects: 53
Study: 25463149

Group type: EXPERIMENTAL
Intervention: Improvement plans focusing on CVRM in intervention group (n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n=23) focusing on any domain except CVRM and diabetes mellitus
Number of subjects: 45
Study: 22891826

Group type: EXPERIMENTAL
Intervention: Orbital Atherectomy + Balloon Angioplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Balloon Angioplasty alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Residual stenosis >30%
Number of subjects: 50
Study: 19703826

Group type: EXPERIMENTAL
Intervention: High frequency chest wall oscillation (HFCWO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual airway clearance techniques (ACTs)
Number of subjects: 29
Study: 18940714

Group type: EXPERIMENTAL
Intervention: Peppermint and neroli hydrolat spray
Number of subjects: 44

Group type: COMPARATOR
Intervention: Plain water spray
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both sprays
Number of subjects: 44